About Halo Pharma
Halo Pharma is a Healthcare company based in Hanover (United States) founded in 2006, and was acquired by Cambrex in July 2018. Contract development and manufacturing for pediatric dosage forms are provided. Halo Pharma offers products and services including Formulation Development, Clinical Supply, Commercial Manufacturing, and Analytical Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Halo Pharmaceutical is a contract development and manufacturing organization which specializes in pediatric dosage forms. Services offered include pharmaceutical development, commercial manufacturing, analytical services for APIs and testing services. Pharmaceutical development services offered include project management, formulation development and analytical development. It has acquired manufacturing facilities from companies like Abbott and Teva to meet the commercial manufacturing needs of its clients by supplying solids, liquids, sterile ointment and packaging services. It also offers chemical and analytical services for pharmaceutical key intermediates and API from development to small-scale commercial production. Testing services offered include chemical and microbiological testing of a complete range of dosage form. Recently, it entered into agreement with Exx pharma to Collaborate on the DevelopmentManufacturing of Products using Twin Screw Extrusion Technology.
- Headquarters Hanover, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website halopharma.com
- Social LinkedIn
- Acquired by Cambrex (Jul 2018)
Products & Services of Halo Pharma
Halo Pharma offers a comprehensive portfolio of products and services, including Formulation Development, Clinical Supply, Commercial Manufacturing, and Analytical Services.
Services for creating pharmaceutical formulations and testing.
Provision of supplies for clinical trials and registration.
Large-scale production of drug products and packaging.
Laboratory testing for pharmaceutical stability and validation.
Funding Insights of Halo Pharma
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Halo Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | Private Equity Round | β | β |
2 investors in total: 2 institutional.
Investors in Halo Pharma
Halo Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Cambrex and SK Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A global private investment firm focused on specialty sectors. | skcapitalpartners.com | New York, United States | ||
CDMO of complex small molecule APIs, including highly potent APIs | 1981 | cambrex.com | East Rutherford, United States |
Investor details for Halo Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Halo Pharma
3 dated milestones of Halo Pharma across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Halo Pharma is founded.
- Funding First funding round.
- Exit Acquired by Cambrex.
Web traffic of Halo Pharma
The website of Halo Pharma (halopharma.com) receives about 3.2K visits a month and ranks #13,721,549 among all websites worldwide, #8,485 in Biotechnology and Pharmaceuticals.
- Monthly visits3.2K
▲ 175.7% vs previous month
- Global rank#13,721,549
among all websites
- Category rank#8,485
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.1
- DevicesDesktop 33% Β· Mobile 67%
Websites whose visitors overlap most with Halo Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
zafa.com.pk | zafa.com.pk | 100% | #13,024,625 | β | |
halobio.com | halobio.com | 99% | β | ||
| colorcon.com | 99% | 47.4K | #759,642 | View details | |
| c-mlabs.com | 94% | View details | |||
| suprachemicals.com | 72% | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Halo Pharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Halo Pharma
Complete news archive for Halo Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Halo Pharma
Halo Pharma was founded in 2006 and raised its 1st funding round 9 years after it was founded.
Halo Pharma is headquartered in Hanover, United States. It is registered at Hanover, New Hampshire, United States.
Halo Pharmaceutical is a contract development and manufacturing organization which specializes in pediatric dosage forms. Services offered include pharmaceutical development, commercial manufacturing, analytical services for APIs and testing services. Pharmaceutical development services offered include project management, formulation development and analytical development. It has acquired manufacturing facilities from companies like Abbott and Teva to meet the commercial manufacturing needs of its clients by supplying solids, liquids, sterile ointment and packaging services. It also offers chemical and analytical services for pharmaceutical key intermediates and API from development to small-scale commercial production. Testing services offered include chemical and microbiological testing of a complete range of dosage form. Recently, it entered into agreement with Exx pharma to Collaborate on the DevelopmentManufacturing of Products using Twin Screw Extrusion Technology.
Halo Pharma offers Formulation Development, Clinical Supply, Commercial Manufacturing, and Analytical Services.
Halo Pharma has 2 investors. Key investors include Cambrex, and SK Capital.
Yes. Halo Pharma was acquired by Cambrex in July 2018.

